Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.93%
1,093.07
+10.03
+0.93%
1,083.041,082.631,094.711,080.59
SIXC
Communications
SIXC
Communications
SIXC
+0.34%
604.41
+2.03
+0.34%
602.38602.38604.95599.75
SIXE
Energy
SIXE
Energy
SIXE
+1.03%
1,255.66
+12.83
+1.03%
1,242.831,229.311,256.581,220.51
SIXI
Industrials
SIXI
Industrials
SIXI
+2.45%
1,755.85
+42.03
+2.45%
1,713.821,715.471,756.631,715.47
SIXM
Financials
SIXM
Financials
SIXM
+0.36%
642.32
+2.33
+0.36%
639.99636.98642.82631.81
SIXR
Staples
SIXR
Staples
SIXR
+1.36%
848.88
+11.42
+1.36%
837.46840.30852.15840.30
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.21%
216.81
+2.59
+1.21%
214.22214.22217.26214.05
SIXT
Technology
SIXT
Technology
SIXT
-0.39%
3,191.99
-12.39
-0.39%
3,204.383,215.043,215.043,159.90
SIXU
Utilities
SIXU
Utilities
SIXU
+2.04%
944.22
+18.84
+2.04%
925.38927.91948.11927.91
SIXV
Health care
SIXV
Health care
SIXV
+2.23%
1,474.84
+32.13
+2.23%
1,442.711,443.011,476.181,443.01
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.35%
2,369.70
+8.36
+0.35%
2,361.342,391.002,395.822,354.52
SABS:NASDAQ
SAB Biotherapeutics Inc
$3.71
+6.61%
(+0.23) 1D
Apr 30, 12:14:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SABS...
Open
$3.49
High
$3.84
Low
$3.49
Mkt. cap
247.99M
Avg. vol.
785.46K
Volume
463.08K
P/E ratio
53.40
52-wk high
$6.60
52-wk low
$1.30
EPS
$0.07
Beta
0.60
Shares outstanding
50.95M
No. of employees
86
News stories
From sources across the web
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Websitesab.bio
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
7.66M
-6.98M
489.95K
32.18M
Cost of revenue
7.66M
-6.98M
489.95K
32.18M
Research and development expenses
-
13.97M
8.48M
-22.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.11M
2.74M
3.71M
6.04M
Operating expense
3.11M
16.71M
12.19M
-16.41M
Total operating expenses
10.77M
9.73M
12.68M
15.77M
Operating income
-10.77M
-9.73M
-12.68M
-15.77M
Other non operating income
5.58M
-331.43K
57.51M
-1.73M
EBT including unusual items
-5.20M
-10.11M
45.45M
-16.86M
EBT excluding unusual items
-5.20M
-10.11M
45.45M
-16.86M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.20M
-10.11M
45.45M
-16.86M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-0.41
Interest and investment income
62.50K
13.56K
655.23K
700.74K
Interest expense
-69.56K
-64.34K
-43.29K
-63.46K
Net interest expenses
-7.07K
-50.78K
611.94K
637.28K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.99M
-8.96M
-11.91M
-15.01M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more